{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:01Z","timestamp":1794047461897,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"6","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284299","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:33:42Z","timestamp":1708576422000},"page":"1966-1972","source":"Crossref","is-referenced-by-count":3,"title":["TENT5C\/FAM46C modulation &lt;i&gt;in vivo&lt;\/i&gt; reveals a trade-off between antibody secretion and tumor growth in multiple myeloma"],"prefix":"10.3324","volume":"109","author":[{"given":"Massimo","family":"Resnati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pennacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Perini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Materozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Orfanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bordini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Nuvolone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Da Vi\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"62466","doi-asserted-by":"crossref","unstructured":"Barbieri M, Manzoni M, Fabris S. Compendium of FAM46C gene mutations in plasma cell dyscrasias. Br J Haematol. 2016; 174(4):642-645.","DOI":"10.1111\/bjh.13793"},{"key":"62467","doi-asserted-by":"crossref","unstructured":"Boyd KD, Ross FM, Walker BA. Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin Cancer Res. 2011; 17(24):7776-7784.","DOI":"10.1158\/1078-0432.CCR-11-1791"},{"key":"62468","doi-asserted-by":"crossref","unstructured":"Bolli N, Biancon G, Moarii M. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leukemia. 2018; 32(12):2604-2616.","DOI":"10.1038\/s41375-018-0037-9"},{"key":"62469","doi-asserted-by":"crossref","unstructured":"Lohr JG, Stojanov P, Carter SL. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014; 25(1):91-101.","DOI":"10.1016\/j.ccr.2013.12.015"},{"key":"62470","doi-asserted-by":"crossref","unstructured":"Mroczek S, Chlebowska J, Kuli\u0144ski TM. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat Commun. 2017; 8(1):619.","DOI":"10.1038\/s41467-017-00578-5"},{"key":"62471","doi-asserted-by":"crossref","unstructured":"Bilska A, Kusio-Kobia\u0142ka M, Krawczyk PS. Immunoglobulin expression and the humoral immune response is regulated by the non-canonical poly(A) polymerase TENT5C. Nat Commun. 2020; 11(1):2032.","DOI":"10.1038\/s41467-020-15835-3"},{"key":"62472","doi-asserted-by":"crossref","unstructured":"Herrero AB, Quwaider D, Corchete LA, Mateos MV, Garc\u00eda-Sanz R, Guti\u00e9rrez NC. FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma. J Cell Mol Med. 2020; 24(7):4171-4182.","DOI":"10.1111\/jcmm.15078"},{"key":"62473","doi-asserted-by":"crossref","unstructured":"Zhu YX, Shi C-X, Bruins LA. Loss of FAM46C promotes cell survival in myeloma. Cancer Res. 2017; 77(16):4317-4327.","DOI":"10.1158\/0008-5472.CAN-16-3011"},{"key":"62474","doi-asserted-by":"crossref","unstructured":"Fucci C, Resnati M, Riva E. The interaction of the tumor suppressor FAM46C with p62 and FNDC3 proteins integrates protein and secretory homeostasis. Cell Rep. 2020; 32(12):108162.","DOI":"10.1016\/j.celrep.2020.108162"},{"key":"62475","doi-asserted-by":"crossref","unstructured":"Manfrini N, Mancino M, Miluzio A. FAM46C and FNDC3A are multiple myeloma tumor suppressors that act in concert to impair clearing of protein aggregates and autophagy. Cancer Res. 2020; 80(21):4693-4706.","DOI":"10.1158\/0008-5472.CAN-20-1357"},{"key":"62476","doi-asserted-by":"crossref","unstructured":"Arendt BK, Ramirez-Alvarado M, Sikkink LA. Biologic and genetic characterization of the novel amyloidogenic lambda light chain\u2013secreting human cell lines, ALMC-1 and ALMC-2. Blood. 2008; 112(5):1931-1941.","DOI":"10.1182\/blood-2008-03-143040"},{"key":"62477","doi-asserted-by":"crossref","unstructured":"Perini T, Materozzi M, Milan E. The immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells. FEBS J. 2022; 289(15):4383-4397.","DOI":"10.1111\/febs.16068"},{"key":"62478","doi-asserted-by":"crossref","unstructured":"Boyle EM, Deshpande S, Tytarenko R. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Nat Commun. 2021; 12(1):293.","DOI":"10.1038\/s41467-020-20524-2"},{"key":"62479","doi-asserted-by":"crossref","unstructured":"Odikadze L, Joseph N, Schmidt TM. Outcomes of myeloma patients with deletion 1p receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy. Blood. 2018; 132(Suppl 1):1884.","DOI":"10.1182\/blood-2018-99-114368"},{"key":"62480","doi-asserted-by":"crossref","unstructured":"Maura F, Boyle E, Coffey D. Genomic determinants of resistance in newly diagnosed multiple myeloma treated with targeted-immunotherapy. Blood. 2022; 140(Suppl 1):1137-1139.","DOI":"10.1182\/blood-2022-160308"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284299\/76629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284299\/77087","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11462\/76629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:50Z","timestamp":1794045950000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284299","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}